Beat top and bottom also kanna

1
Comment
Favorite

romanc9
2025-08-06

Beat top and bottom also kanna wag down but why tesla didn't. Fund managers maybe trying to scare smaller investors to sell and they start accumulate at a lower price.. So retailers investors, if you have extra cash buy more..

Stock Track | Clover Health Plunges 12.28% Pre-market Despite Q2 Revenue Beat as Losses Persist

Clover Health Corp (CLOV) shares tumbled 12.28% in pre-market trading on Wednesday, following the release of its second-quarter 2025 financial results. The significant drop came despite the company...

Stock Track | Clover Health Plunges 12.28% Pre-market Despite Q2 Revenue Beat as Losses Persist

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":464800874861032,"tweetId":"464800874861032","gmtCreate":1754469331307,"gmtModify":1754469376043,"author":{"id":4102495020619380,"idStr":"4102495020619380","authorId":4102495020619380,"authorIdStr":"4102495020619380","name":"romanc9","avatar":"https://static.tigerbbs.com/76bfe37245defa055adfff7453f1520f","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.06","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":30,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>Beat top and bottom also kanna wag down but why tesla didn't. Fund managers maybe trying to scare smaller investors to sell and they start accumulate at a lower price.. So retailers investors, if you have extra cash buy more..&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Beat top and bottom also kanna wag down but why tesla didn't. Fund managers maybe trying to scare smaller investors to sell and they start accumulate at a lower price.. So retailers investors, if you have extra cash buy more..&nbsp;</p></body></html>","text":"Beat top and bottom also kanna wag down but why tesla didn't. Fund managers maybe trying to scare smaller investors to sell and they start accumulate at a lower price.. So retailers investors, if you have extra cash buy more..","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/464800874861032","repostId":1103304891,"repostType":2,"repost":{"id":"1103304891","kind":"news","weMediaInfo":{"introduction":"Track stock‘s movements and relevant news","home_visible":1,"media_name":"Stock Track","id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1754467635,"share":"https://ttm.financial/m/news/1103304891?lang=en_US&edition=fundamental","pubTime":"2025-08-06 16:07","market":"hk","language":"en","title":"Stock Track | Clover Health Plunges 12.28% Pre-market Despite Q2 Revenue Beat as Losses Persist","url":"https://stock-news.laohu8.com/highlight/detail?id=1103304891","media":"Stock Track","summary":"Clover Health Corp (CLOV) shares tumbled 12.28% in pre-market trading on Wednesday, following the release of its second-quarter 2025 financial results. The significant drop came despite the company...","content":"<p>Clover Health Corp (CLOV) shares tumbled 12.28% in pre-market trading on Wednesday, following the release of its second-quarter 2025 financial results. The significant drop came despite the company beating revenue expectations, as ongoing losses and a lack of substantial improvement in profitability disappointed investors.</p>\n\n<p>For the quarter ended June 30, Clover Health reported revenue of $478 million, surpassing the analyst estimate of $468.3 million and representing a 34.1% increase from the same quarter last year. The company also posted an adjusted EBITDA of $17 million, slightly above the expected $16.3 million. However, the health insurer recorded a net loss of $11 million for the quarter, which likely contributed to the sharp stock decline. On a per-share basis, the company reported a loss of 2 cents, which was better than the analysts' expectations of a 3-cent loss but still in negative territory.</p>\n\n<p>Despite the mixed results, Clover Health maintained its full-year 2025 insurance revenue guidance between $1.800 billion and $1.875 billion. This consistency in outlook, however, failed to assuage investor concerns about the company's path to profitability. The significant pre-market drop suggests that market participants were hoping for more robust signs of financial improvement, particularly in terms of bottom-line performance. As Clover Health continues to navigate the competitive healthcare landscape, investors appear to be growing impatient with the company's progress towards sustainable profitability.</p>","source":"ai_movement_en","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Clover Health Plunges 12.28% Pre-market Despite Q2 Revenue Beat as Losses Persist</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Clover Health Plunges 12.28% Pre-market Despite Q2 Revenue Beat as Losses Persist\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-06 16:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Clover Health Corp (CLOV) shares tumbled 12.28% in pre-market trading on Wednesday, following the release of its second-quarter 2025 financial results. The significant drop came despite the company beating revenue expectations, as ongoing losses and a lack of substantial improvement in profitability disappointed investors.</p>\n\n<p>For the quarter ended June 30, Clover Health reported revenue of $478 million, surpassing the analyst estimate of $468.3 million and representing a 34.1% increase from the same quarter last year. The company also posted an adjusted EBITDA of $17 million, slightly above the expected $16.3 million. However, the health insurer recorded a net loss of $11 million for the quarter, which likely contributed to the sharp stock decline. On a per-share basis, the company reported a loss of 2 cents, which was better than the analysts' expectations of a 3-cent loss but still in negative territory.</p>\n\n<p>Despite the mixed results, Clover Health maintained its full-year 2025 insurance revenue guidance between $1.800 billion and $1.875 billion. This consistency in outlook, however, failed to assuage investor concerns about the company's path to profitability. The significant pre-market drop suggests that market participants were hoping for more robust signs of financial improvement, particularly in terms of bottom-line performance. As Clover Health continues to navigate the competitive healthcare landscape, investors appear to be growing impatient with the company's progress towards sustainable profitability.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103304891","content_text":"Clover Health Corp (CLOV) shares tumbled 12.28% in pre-market trading on Wednesday, following the release of its second-quarter 2025 financial results. The significant drop came despite the company beating revenue expectations, as ongoing losses and a lack of substantial improvement in profitability disappointed investors.\nFor the quarter ended June 30, Clover Health reported revenue of $478 million, surpassing the analyst estimate of $468.3 million and representing a 34.1% increase from the same quarter last year. The company also posted an adjusted EBITDA of $17 million, slightly above the expected $16.3 million. However, the health insurer recorded a net loss of $11 million for the quarter, which likely contributed to the sharp stock decline. On a per-share basis, the company reported a loss of 2 cents, which was better than the analysts' expectations of a 3-cent loss but still in negative territory.\nDespite the mixed results, Clover Health maintained its full-year 2025 insurance revenue guidance between $1.800 billion and $1.875 billion. This consistency in outlook, however, failed to assuage investor concerns about the company's path to profitability. The significant pre-market drop suggests that market participants were hoping for more robust signs of financial improvement, particularly in terms of bottom-line performance. As Clover Health continues to navigate the competitive healthcare landscape, investors appear to be growing impatient with the company's progress towards sustainable profitability.","news_type":1,"symbols_score_info":{"CLOV":1}},"isVote":1,"tweetType":1,"viewCount":1500,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":187,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}